CCR6 and neoplasm: CCL20 is a cytokine that can promote Treg cell infiltration, and the CCR6-CCL20 axis regulated Tregs migrate into the tumor microenvironment, thereby leading to tumor progression and poor prognosis in patients with HCC (32–35).